Introduction of magnetic resonance radiation therapy (MR/RT) expected to transform cancer care in
BEIJING, August 21, 2020 - Elekta (EKTA-B.ST) today announced that the world's first high-field 1.5T MR radiation therapy system, Elekta Unity, has received clearance from the
Elekta Unity is a state-of-the art MR-Linac that is setting a new standard for personalized adaptive radiation therapy. Elekta Unity provides the ability to reshape the dose based on daily changes in shape, size and position of the tumor and surrounding healthy anatomy and then enables accurate dose delivery with real-time visualization of the tumor. The system combines a Philips high-field 1.5T MRI scanner with a best-in-class 7MV linear accelerator and breakthrough online dose replanning software that are fully integrated to enable adaptive radiotherapy and real-time target monitoring.
Elekta Unity has followed strict clinical trials in top Chinese hospitals for nearly two years after its introduction, according to new NMPA guidelines. The system has the potential to significantly improve outcomes for people living with cancer and reduce side effects.
Cancer is a leading cause of death in
According to GLOBOCON[[[1]]][ ]statistics, an estimated 4.3 million new cancer cases and 2.9 million new cancer deaths occurred in
To learn more, visit elekta.com/Unity (http://www.elekta.com/unity).
Elekta Unity is CE marked and 510(k) cleared and has received regulatory clearances in
# # #
For further information, please contact:
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
This is information that
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in
[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.
https://news.cision.com/elekta/r/elekta-unity-mr-linac-receives-clearance-by-china-s-national-medical-products-administration,c3177468
https://mb.cision.com/Main/35/3177468/1295336.pdf
https://news.cision.com/elekta/i/elekta-unity,c2814295
(c) 2020 Cision. All rights reserved., source